Publications by authors named "Mark Cornfeld"

Claim this Profile
R
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study.
Shun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, Vladimer Kuchava, Aishah Ibrahim, Mark Cornfeld

Lancet Respir Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).
Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé, Michele Guida, Caroline Gaudy-Marqueste, Mark Cornfeld

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial.
Sheela Rao, Emmanuelle Samalin-Scalzi, Ludovic Evesque, Meher Ben Abdelghani, Federica Morano, Mark Cornfeld

Lancet· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study.
Dominique Berton, Patricia Pautier, Domenica Lorusso, Christine Gennigens, Laurence Gladieff, Mark Cornfeld

Gynecol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31Annual Meeting of the Society for Immunotherapy of Cancer, 2016.
Prasad S Adusumilli, Edward Cha, Mark Cornfeld, Thomas Davis, Adi Diab

J Immunother Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.
Robert J Arceci, Carl E Allen, Ira J Dunkel, Eric Jacobsen, James Whitlock, Mark Cornfeld

Pediatr Blood Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.
Anthony W Tolcher, Amita Patnaik, Kyriakos P Papadopoulos, Drew W Rasco, Carlos R Becerra, Mark Cornfeld

Cancer Chemother Pharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer.
Gary Hudes, Scott T Tagawa, Young E Whang, Ming Qi, Xiang Qin, Mark Cornfeld

Invest New Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.
Sally A Hunsucker, Valeria Magarotto, Deborah J Kuhn, Steven M Kornblau, Michael Wang, Mark Cornfeld

Br J Haematol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.
Frits van Rhee, Luis Fayad, Peter Voorhees, Richard Furman, Sagar Lonial, Mark Cornfeld

J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in worksite smoking behavior following cancer risk feedback: a pilot study.
Robert A Schnoll, Hao Wang, Suzanne M Miller, James S Babb, Mark J Cornfeld

Am J Health Behav· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological issues related to the use of spiral CT for lung cancer early detection.
Robert A Schnoll, Pamela Bradley, Suzanne M Miller, Michael Unger, James Babb, Mark Cornfeld

Lung Cancer· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a comprehensive cancer control program at the worksite: year one summary report.
Mark J Cornfeld, Robert A Schnoll, Susan Higman Tofani, James S Babb, Suzanne M Miller

J Occup Environ Med· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancer.
John C Marsh, Paul Catalano, Jie Huang, David L Graham, Mark J Cornfeld

Clin Colorectal Cancer· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis